-
BRI Deploys Teras BRI Ships to Provide Vaccination in the Maluku Islands
prnasia
July 12, 2021
PT Bank Rakyat Indonesia (Persero) Tbk is committed to supporting the success of the COVID-19 vaccination program that is being carried out by the Government as an effort to overcome the pandemic.
-
Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization
prnasia
July 12, 2021
Ortho Clinical Diagnostics announced its VITROS® Anti-SARS-CoV-2 IgG Quantitative Test is the first quantitative COVID-19 IgG antibody test to receive U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
-
Long-COVID symptoms improved with neuromodulation
europeanpharmaceuticalreview
July 12, 2021
All twenty long-COVID patients who received neuromodulation treatment reported significant improvements in their symptoms in just 14 days.
-
Study notes COVID-19 most likely caused by animal source, not of lab origin
expresspharma
July 12, 2021
The study noted that while a laboratory accident "cannot be entirely dismissed", there currently exists zero evidence for such a lab origin of the virus behind the COVID-19 pandemic.
-
ICMR proposes clinical trial along with Oxford University to evaluate COVID-19 therapy
expresspharma
July 12, 2021
The trial -- 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)'-- will be a multi-centre, adaptive platform trial on Covid patients, ICMR said.
-
CDC: Vaccinated Teachers, Students Can Skip Masks This Fall
drugs
July 12, 2021
When schools open their doors this fall, teachers and students who are vaccinated can enter without masks, according to new guidance issued Friday by the U.S. Centers for Disease Control and Prevention.
-
COVID-19 vaccines highly effective in most people in clinical risk groups
firstwordpharma
July 12, 2021
The study from Public Health England (PHE) included more than 1 million people in at-risk groups.
-
OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks
firstwordpharma
July 12, 2021
The Netherlands' Outbreak Management Team (OMT) expressed doubts about whether Johnson & Johnson's single-dose COVID-19 vaccine offers sufficient protection against the Delta variant, reported NL Times.
-
Israeli co Bonus BioGroup reports Covid-19 treatment success
firstwordpharma
July 12, 2021
In an Israeli trial, severely ill patients treated with Bonus BioGroup's stem-cell based product MesenCure showed significant improvement, reported Globes.
-
Sputnik V gives 90% protection against Delta strain of Covid-19: Scientist
firstwordpharma
July 12, 2021
Viral vector and mRNA vaccines, including Russia's Sputnik V, provide enough protection against the new Delta strain of the coronavirus, albeit to a lesser extent, reported The Times of India.